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Abstract
Background: The identification of clinical factors associated with negative blood cultures could
help to avoid unnecessary blood cultures. C-reactive protein (CRP) is a well-established
inflammation marker commonly used in the management of medical inpatients.
Methods:  We studied the association of clinical factors, CRP levels and changes of CRP
documented prior to blood culture draws with the absence of bacteremia for hospitalized medical
patients.
Results: In the retrospective analysis of 710 blood cultures obtained from 310 medical inpatients
of non-intensive-care wards during one year (admission blood cultures obtained in the emergency
room were excluded), the following retrospectively available factors were the only independent
predictors of blood cultures negative for obligate pathogens: a good clinical condition represented
by the lowest of three general nursing categories (OR 4.2, 95% CI 1.8 – 9.5), a CRP rise > 50 mg/
L documented before the blood culture draw (OR 2.0 95% CI 1.8–9.5) and any antibiotic treatment
in the previous seven days (OR 2.0, 95% CI 1.1–3.5).
Conclusion: Including the general clinical condition, antibiotic pre-treatment and a substantial rise
of CRP into the decision, whether or not to obtain blood cultures from medical inpatients with a
suspected infection, could improve the diagnostic yield.
Background
Blood cultures (BC) are especially important in the diag-
nosis of endovascular infections. At the same time, the
benefits and cost effectiveness of blood culture diagnosis
for many other infectious syndromes are less clearly
defined. The identification of clinical factors associated
with negative blood cultures could help to avoid unneces-
sary BC. Serum C-reactive protein (CRP) is a well-estab-
lished marker of inflammation [1,2]. It is commonly used
in many clinical settings to evaluate and monitor severity
of disease in patients with presumed infections [1]. We
aimed to evaluate associations of different CRP levels or
changes in CRP prior to BC draw with subsequent BC
results. The association of negative BC results with other
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clinical factors commonly used to decide whether a BC
draw is indicated and available by chart review were stud-
ied additionally.
Methods
At our tertiary care university hospital, we reviewed medi-
cal charts of all 363 patients from three general internal
medicine non-intensive-care wards with at least one BC
draw in the year 2000 (blood volume per BC app. 15 – 20
mL, split and cultivated in an aerobic and an anaerobic
bottle, BacT/Alert™, Organon Teknika, Durham, NC).
During the study period, no formal guidelines for the
indication of BC existed in our department. Ordering BC
was therefore solely based on the judgement of the treat-
ing physicians.
Clinical relevance of skin flora isolated in BC (coagulase-
negative staphylococci, Corrynebacterium spp., and Propi-
onibacterium spp.) is difficult to determine, even prospec-
tively. Therefore in our retrospective study, these bacterial
species were regarded as either contaminations or the
cause of endovascular catheter infections and were
excluded from the analysis. All other isolated pathogens
were considered to be obligate pathogens (OP).
We retrieved the following variables – all of which had
been available to treating physicians at the time point of
BC-collection – and evaluated their association with BC
results: BC draw in the emergency room (ER) or intensive
care unit (ICU) in the previous 3 days; any antibiotic treat-
ment in the previous 7 days; any intravenous antibiotics
in previous 2 days; lack of high fever (temperature of <
40°C); absence of documented substantial temperature
rise (no rise or rise of < 2°C); absence of white blood cell
count (WBC) elevation (value of < 12/nL); absence of a
documented substantial WBC increase (no rise or rise < 2/
nL); substantial (value of > 100 mg/L) elevation of CRP
level; documented substantial rise of CRP (rise of > 50
mg/L); lowest general nursing category (reflecting
dependence on help with daily activities, 1 vs. 2 or 3, as
surrogate markers for the patients' overall clinical condi-
tion); age below 60 years. Only observations documented
within 24 hours before the BC draw (within 48 h for WBC
and CRP values) were included in the analysis. All factors
reflecting changes over time were determined by the sub-
traction of the two most recent values obtained before the
BC draw which were at least 24 hours apart. Additionally
the main hospital discharge diagnosis of all patients with
BC draws was obtained.
Crude analyses were performed using χ2-test, and
adjusted analyses, using logistic regression, with the final
predictive model derived by a backward elimination
(exclusion criterion, p > 0.05). All analyses were per-
formed using SAS software (SAS Institute Inc. Cary, NC).
The research was conducted in accordance with require-
ments set for retrospective studies by the local ethics com-
mittee (ethics committee of the University of Regensburg,
Germany).
Results
A total of 856 BC from 363 patients on three analyzed
non-ICU wards in the year 2000 were identified. 710
(83%) of BC of 310 (85%) patients had sufficient clinical
documentation to be included in the analysis. 96 (13%)
of 710 BC were positive, and in 91 the species could be
identified. Thirty-two results were regarded as contamina-
tion or as related to endovascular catheter infection (coag-
ulase-negative staphylococci (n = 30), Corrynebacterium
spp. (n = 1), Propionibacterium acnes (n = 1)), and remain-
ing 59 as obligate pathogens (OP): Gram-negative bacte-
ria n = 35; Gram-positive bacteria n = 16; Candida spp. n
= 8). Comprising blood cultures drawn within 3 days as
one diagnostic episode (DE), there were 426 DE, 41
(10%) of which yielded OP. Of the 157 DE with more
than 1 BC, 17 (11%) DE yielded OP. An analysis stratified
by the amount of BC per DE (1–2 vs. 3 or more BC per
DE) did not reveal a significant difference in the rate of
OP-positive results (35/445 (7.9%) vs. 24/265 (9.1%) p =
0.57 by χ2-test). Furthermore, an analysis stratified by
hospital day (BC obtained on day 1 and 2 vs. > day 2 of
the hospital stay) showed no significant difference in the
rate of OP-positve BC: 25/330 (7.6%) vs. 34/380 (8.9%);
(p = 0.51 by χ2-test).
There were no significant differences (χ2-test for 5 strata, p
= 0.63) in the crude rates of OP-positive BC across strata
of CRP values determined prior to drawing the BC: 0 – 5
mg/L (normal range) 2/20 (10.0%), 6–50 mg/L 15/196
(7.7%), 51–100 mg/L 14/133 (10.6%), 101–200 mg/L
14/219 (6.4%), and CRP > 200 mg/L 14/141 (9.9%).
There was a significant difference (χ2-test for 4 strata, p =
0.008) in the crude rates of OP-positive BC among strata
of the documented change of CRP prior to drawing the
BC: any fall in CRP 11/207 (5.3%), CRP rise between 1
and 50 mg/L 31/261 (11.9%), CRP rise > 50 mg/L 4/102
(3.9%), and change not applicable (only one CRP value
determined prior to drawing the BC) 13/140 (9.3%). This
difference remained statistically significant analyzing only
the subgroup of 291BC from patients with no antibiotic
therapy in the previous 7 days. For the subgroup of 61 BC
from patients with any antibiotic therapy in the previous
7 days and a substantial rise of CRP (> 50 mg/L) prior to
drawing the BC, the number of BC needed to diagnose
one OP was 20 (61/3).
A summary of crude and adjusted analyses is shown in
Additional file 1. In the crude analysis, the following fac-
tors were significantly associated with OP-negative BC: BC
draw in the ER or ICU in the previous 3 days, absence ofBMC Infectious Diseases 2008, 8:148 http://www.biomedcentral.com/1471-2334/8/148
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high fever, absence of a documented substantial tempera-
ture rise, absence of a documented substantial rise of the
WBC, and the lowest general nursing category. After con-
sidering all factors simultaneously in the logistic regres-
sion model (c-statistic 0.665; Hosmer-Lemeshow
goodness-of-fit statistic 0.612; discordant prediction
20.4%), low general nursing category (odds ratio (OR)
4.2), a CRP rise > 50 mg/L (OR 2.0), and any antibiotic in
the previous 7 days (OR 2.0) remained significantly (p <
0.05) associated with OP-negative BC.
Analyzing the main hospital discharge diagnosis, 23/332
(6.9%) BC drawn from patients with a non-infectious and
36/458 (7.9%) BC drawn from patients with an infectious
main hospital discharge diagnosis were OP-positive.
Among BC obtained from patients with infectious main
hospital discharge diagnosis, OP-positive rates were as fol-
lows: abdominal infections 24/154 (15.6%); soft tissue
infections 1/58 (1.7%); respiratory infections 1/86
(1.2%); sepsis 8/47 (17.0%); catheter infections 0/10
(0%); urogenital infections 0/9 (0%); infections in HIV-
positive patients 0/9 (0%); endocarditis 2/2 (100%);
meningitis 0/3 (0%).
Discussion
Several major studies have identified clinical factors and
derived clinical prediction models for positive BC results
[3-5]. These studies did not assess the role of CRP. We
evaluated the association of CRP values and CRP change
prior to obtaining BC with OP-negative BC results in adult
internal medicine non-ICU patients and compared this
association with that of selected other factors, commonly
used in the decision on ordering BC available by chart
review.
The level of CRP available before drawing the BC showed
no association with BC results in our analysis. In accord-
ance, a study of CRP values on the day of BC draw in
patients with bacteremia showed no significant difference
for CRP levels between OP-positive BC and contamina-
tion-positive BC [6]. Several studies, assessing the useful-
ness of CRP measured at the onset of fever in adult
neutropenic cancer patients, showed no significant associ-
ation [7,8] or only a modest association with the presence
of bacteremia [9]. In a retrospective analysis of adult inpa-
tients with sepsis syndrome without shock, there was no
significant difference of CRP values between bacteremic
and non-bacteremic patients at the time of obtaining the
BC [10]. Contrary to these studies, Tokuda et al. found in
a population with a low prevalence (4%) of malignant
conditions a significant difference of CRP values between
bacteremic and non-bacteremic ER patients with sus-
pected infections [11]. They therefore included the varia-
ble of CRP < 100 mg/L in a classification algorithm for
low risk of bacteremia.
There was an association between a substantial (> 50 mg/
L) rise in CRP determined prior to BC draw and OP-nega-
tive BC in this study. To our knowledge, so far no study
has assessed changes of CRP prior to BC draw as a predic-
tor for bacteremia among general internal medicine adult
inpatients. At a first glance, it seems counterintuitive that
a rise of an inflammation marker is associated with low
prevalence of bacteremia. We speculate that this finding
could be explained by the time-dependent course of CRP
level after an inflammatory stimulus. Rintala and co-
workers showed that CRP levels peak between 24 and 48
h after admission for an infection [2,12]. Therefore, a sub-
stantial rise of CRP could indicate diagnostic situations,
where the inflammatory stimulus – e.g. transient bactere-
mia – may already have disappeared by the time the BC is
drawn. This hypothesis is supported by our finding of a
low prevalence of OP-positive BC not only with a prior
rise but also obtained after having passed a peak of CRP
values prior to obtaining BC.
A good overall clinical condition of the patient repre-
sented by the lowest of the 3 general nursing categories
had the strongest association with OP-negative BC. We
did not to evaluate disease-specific anamnestic informa-
tion in our retrospective chart-based analysis. Therefore,
the strong association of the overall clinical condition
with BC results in the regression model was not surpris-
ing.
There are some limitations to our study. The retrospective
design excluded the evaluation of certain anamnestic
information and physical findings as competing clinical
predictors. By design, we excluded BC from patients
treated in the ICU. Therefore, our results might not apply
to critical ill patients with a very high probability of bac-
teremia. The measurement of CRP was not performed at
exactly specified time-points in relation to the obtaining
of the BC. During the period studied, the measurement of
procalcitonin as an inflammatory marker was clinically
not available at our institution; therefore we could not
evaluate the association of this promising new inflamma-
tory marker with BC results in our retrospective cohort
[13]. Because of the low frequency of positive BC, we
refrained from splitting our cohort in a derivation and a
validation sample. Many (46.8%) BC in our study were
obtained from patients where the infection or presumed
infection was not the main hospital discharge diagnosis.
Therefore, our results should be confirmed in other clini-
cal settings and especially the change of CRP prior to
obtaining BC should be included in further prospective
studies to learn more about the generalisability of our
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Conclusion
The low rate of positive BC obtained from adult non-ICU
inpatients with a passed or recent peak in CRP could be
useful in the decision whether to draw or not to draw a
blood culture. Recent changes in CRP or other inflamma-
tory markers should be evaluated prospectively as candi-
date factors in future decision rules. Including the general
clinical condition, antibiotic pre-treatment and a substan-
tial rise of CRP into the decision, whether or not to obtain
blood cultures from medical inpatients with a suspected
infection, has the potential to improve the diagnostic
yield of BC by refraining from BC-collection in situations
with low positive-rates and therefore might lower costs.
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